More Realistic Forecasting of Future Life Events After Psilocybin for Treatment-Resistant Depression Read More > October 12, 2018
Ibogaine as a treatment for substance misuse: Potential benefits and practical dangers. Read More > October 12, 2018
The neuropharmacology of sleep paralysis hallucinations: serotonin 2A activation and a novel therapeutic drug Read More > October 5, 2018
Repeat-dose ketamine augmentation for treatment-resistant depression with chronic suicidal ideation: A randomized, double blind, placebo controlled trial. Read More > September 17, 2018
Reduction in social anxiety after MDMA-assisted psychotherapy with autistic adults: a randomized, double-blind, placebo-controlled pilot study. Read More > September 8, 2018
Reduction in social anxiety after MDMA-assisted psychotherapy with autistic adults: a randomized, double-blind, placebo-controlled pilot study. Read More > September 8, 2018
Rapid effectiveness of intravenous ketamine for ultraresistant depression in a clinical setting and evidence for baseline anhedonia and bipolarity as clinical predictors of effectiveness Read More > September 5, 2018
